Intracellular antibodies and challenges facing their use as therapeutic agents

被引:76
作者
Lobato, MN [1 ]
Rabbitts, TH [1 ]
机构
[1] MRC, Mol Biol Lab, Cambridge CB2 2QH, England
基金
英国医学研究理事会;
关键词
D O I
10.1016/S1471-4914(03)00163-1
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A key feature of antibodies is their ability to bind antigens with high specificity and affinity. This has led to the concept of intracellular antibodies (intrabodies), designed to mimic antibody-antigen binding, but inside cells. Antibody fragments comprising the antigen-binding variable domains are convenient formats for intrabodies, potentially allowing for intracellular functionality. Intrabodies are promising tools, capable of interfering with a wide range of molecular targets in various intracellular compartments. However, many significant challenges remain to be overcome before intrabodies can be useful therapeutic agents. Although major progress has been made in the design and selection of intrabodies, new developments and advances are needed to allow their efficient delivery and expression for treatment of human diseases.
引用
收藏
页码:390 / 396
页数:7
相关论文
共 61 条
[1]   Ligand-targeted therapeutics in anticancer therapy [J].
Allen, TM .
NATURE REVIEWS CANCER, 2002, 2 (10) :750-763
[2]  
Alvarez RD, 2000, CLIN CANCER RES, V6, P3081
[3]   Antineoplastic effect of anti-erbB-2 intrabody is not correlated with scFv affinity for its target [J].
Arafat, W ;
Gómez-Navarro, J ;
Xiang, JL ;
Siegal, GP ;
Alvarez, RD ;
Curiel, DT .
CANCER GENE THERAPY, 2000, 7 (09) :1250-1256
[4]   Effective single chain antibody (scFv) concentrations in vivo via adenoviral vector mediated expression of secretory scFv [J].
Arafat, WO ;
Gómez-Navarro, J ;
Buchsbaum, DJ ;
Xiang, J ;
Wang, M ;
Casado, E ;
Barker, SD ;
Mahasreshti, PJ ;
Haisma, HJ ;
Barnes, MN ;
Siegal, GP ;
Alvarez, RD ;
Hemminki, A ;
Nettelbeck, DM ;
Curiel, DT .
GENE THERAPY, 2002, 9 (04) :256-262
[5]   Inhibition of Tat-mediated transactivation and HIV-1 replication by human anti-hCyclinT1 intrabodies [J].
Bai, JR ;
Sui, JH ;
Zhu, RY ;
Tallarico, AS ;
Gennari, F ;
Zhang, DS ;
Marasco, WA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (03) :1433-1442
[6]   EXPRESSION AND TARGETING OF INTRACELLULAR ANTIBODIES IN MAMMALIAN-CELLS [J].
BIOCCA, S ;
NEUBERGER, MS ;
CATTANEO, A .
EMBO JOURNAL, 1990, 9 (01) :101-108
[7]   INTRACELLULAR EXPRESSION OF ANTI-P2L(RAS) SINGLE-CHAIN FV FRAGMENTS INHIBITS MEIOTIC MATURATION OF XENOPUS-OOCYTES [J].
BIOCCA, S ;
PIERANDREIAMALDI, P ;
CATTANEO, A .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1993, 197 (02) :422-427
[8]   INTRACELLULAR IMMUNIZATION WITH CYTOSOLIC RECOMBINANT ANTIBODIES [J].
BIOCCA, S ;
PIERANDREIAMALDI, P ;
CAMPIONI, N ;
CATTANEO, A .
BIO-TECHNOLOGY, 1994, 12 (04) :396-399
[9]   SINGLE-CHAIN ANTIGEN-BINDING PROTEINS [J].
BIRD, RE ;
HARDMAN, KD ;
JACOBSON, JW ;
JOHNSON, S ;
KAUFMAN, BM ;
LEE, SM ;
LEE, T ;
POPE, SH ;
RIORDAN, GS ;
WHITLOW, M .
SCIENCE, 1988, 242 (4877) :423-426
[10]   A system for stable expression of short interfering RNAs in mammalian cells [J].
Brummelkamp, TR ;
Bernards, R ;
Agami, R .
SCIENCE, 2002, 296 (5567) :550-553